CanakinumabCanakinumab is a human monoclonal antibody directed against interleukin 1 beta (IL1B). Canakinumab is being used in the treatment of of cryopyrin-associated periodic syndromes (CAPS).
What can Sanquin do for you?
- Measure drug levels of free drug in the serum using an validated ELISA.
- Measure the immunogenicity of canakinumab.
- Provide assay reagents or co-develop novel testing strategies.
- Folllowing ISO, FDA/EMA, RUO guidelines.
Enquire about our drug level and ADA assays by emailing us at [email protected].